Published in Eur Urol on August 18, 2006
Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) (SOAP) | NCT03297281
2010 Update: Guidelines for the management of benign prostatic hyperplasia. Can Urol Assoc J (2010) 1.56
Safety and effectiveness of Thulium VapoEnucleation of the prostate (ThuVEP) in patients on anticoagulant therapy. World J Urol (2013) 1.49
Complications of laser prostatectomy: a review of recent data. World J Urol (2010) 1.22
Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia. Can Urol Assoc J (2008) 1.09
Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol (2009) 1.04
Prostate histotripsy in an anticoagulated model. Urology (2009) 0.98
The evolution of KTP laser vaporization of the prostate. Yonsei Med J (2008) 0.92
Long-Term Follow-Up Results of Photoselective Vaporization of the Prostate with the 120 W Greenlight HPS Laser for Treatment of Benign Prostatic Hyperplasia. Korean J Urol (2011) 0.91
Prevention and management of TURP-related hemorrhage. Nat Rev Urol (2011) 0.90
New techniques for laser prostatectomy: an update. Ther Adv Urol (2009) 0.90
Comparison of the haemostatic properties of conventional monopolar and bipolar transurethral resection of the prostate in patients on oral anticoagulants. Arch Med Sci (2011) 0.88
The 80-W KTP GreenLight laser vaporization of the prostate versus transurethral resection of the prostate (TURP): adjusted analysis of 5-year results of a prospective non-randomized bi-center study. Lasers Med Sci (2015) 0.85
Impact of oral anticoagulation on morbidity of transurethral resection of the prostate. World J Urol (2010) 0.85
Photoselective vaporization of prostate vs. transurethral resection of prostate: A prospective, randomized study with one year follow-up. Indian J Urol (2012) 0.84
An Analytical Comparison of Short-term Effectiveness and Safety Between Thulium:YAG Laser Vaporesection of the Prostate and Bipolar Transurethral Resection of the Prostate in Patients With Benign Prostatic Hyperplasia. Korean J Urol (2014) 0.81
Laser prostatectomy: holmium laser enucleation and photoselective laser vaporization of the prostate. Rev Urol (2013) 0.81
Efficacy and safety of 120-W GreenLight High-Performance System laser photo vaporization of the prostate: 3-year results with specific considerations. Prostate Int (2013) 0.80
Greenlight high-performance system (HPS) 120-W laser vaporization versus transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a meta-analysis of the published results of randomized controlled trials. Lasers Med Sci (2016) 0.79
The application of 120-W high-performance system GreenLight laser vaporization of the prostate in high-risk patients. Lasers Med Sci (2012) 0.79
Photoselective vaporization of the prostate in men taking clopidogrel. Urol Ann (2011) 0.78
Influence of intravesical prostatic protrusion on preoperative lower urinary tract symptoms and outcomes after 120 w high performance system laser treatment in men with benign prostatic hyperplasia. Korean J Urol (2012) 0.78
A survey of the peri-operative management of urological patients on clopidogrel. Ann R Coll Surg Engl (2009) 0.78
Comparison between complication rates of laser prostatectomy electrocautery transurethral resection of the prostate: A population-based study. Can Urol Assoc J (2014) 0.78
Safety, efficacy and outcomes of the new GreenLight XPS 180W laser system compared to the GreenLight HPS 120W system for the treatment of benign prostatic hyperplasia in a prospective nonrandomized single-centre study. Can Urol Assoc J (2015) 0.77
Photoselective vaporization of the prostate with GreenLight 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis of randomized controlled trials. Lasers Med Sci (2015) 0.77
Benign Prostatic Hyperplasia: Review of Modern Minimally Invasive Surgical Treatments. Semin Intervent Radiol (2016) 0.75
Plasmakinetic enucleation of prostate versus 160-W laser photoselective vaporization for the treatment of benign prostatic hyperplasia. Asian J Androl (2016) 0.75
Holmium laser enucleation of the prostate: patient selection and perspectives. Res Rep Urol (2016) 0.75
Durability and complications of photoselective vaporisation of the prostate with the 120W high performance system GreenLight™ lithium triborate laser. Ann R Coll Surg Engl (2014) 0.75
Overview of interventional treatment options for benign prostatic hyperplasia. Can Urol Assoc J (2012) 0.75
Elective Urological Surgery Following Coronary Stent Implantation: To Whom, How To Do It? Curr Urol (2014) 0.75
[Prostate laser photovaporisation in patients at high risk of bleeding]. Pan Afr Med J (2013) 0.75
Medical and Surgical Treatment Modalities for Lower Urinary Tract Symptoms in the Male Patient Secondary to Benign Prostatic Hyperplasia: A Review. Semin Intervent Radiol (2016) 0.75
Therapeutic options in the treatment of benign prostatic hyperplasia. Patient Prefer Adherence (2009) 0.75
Impact of preoperative haemoglobin concentrations on the efficiency of KTP-laser vaporization of the prostate. World J Urol (2009) 0.75
GreenLight laser photoselective vaporization of the prostate for treatment of benign prostate hyperplasia/lower urinary tract symptoms in patients with different post-void residual urine. Lasers Med Sci (2017) 0.75
Optimising patient outcomes with photoselective vaporization of the prostate (PVP): a review. Transl Androl Urol (2017) 0.75
EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol (2013) 4.89
Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer. Eur Urol (2010) 4.60
Urethral stricture: etiology, investigation and treatments. Dtsch Arztebl Int (2013) 3.57
Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol (2008) 3.37
Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol (2009) 2.99
Insignificant prostate cancer and active surveillance: from definition to clinical implications. Eur Urol (2009) 2.97
Downsides of robot-assisted laparoscopic radical prostatectomy: limitations and complications. Eur Urol (2009) 2.76
Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer. Sci Transl Med (2012) 2.64
Laser therapy for upper urinary tract transitional cell carcinoma: indications and management. Eur Urol (2008) 2.43
Robotic-assisted laparoscopic extended pelvic lymph node dissection for prostate cancer: surgical technique and experience with the first 99 cases. Eur Urol (2008) 2.42
GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol (2008) 2.33
Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol (2010) 2.30
Mid-term results for the retroluminar transobturator sling suspension for stress urinary incontinence after prostatectomy. BJU Int (2010) 2.26
The "all-seeing needle": initial results of an optical puncture system confirming access in percutaneous nephrolithotomy. Eur Urol (2011) 2.13
Repeat retrourethral transobturator sling in the management of recurrent postprostatectomy stress urinary incontinence after failed first male sling. Eur Urol (2010) 2.11
Dual energy CT characterization of urinary calculi: initial in vitro and clinical experience. Invest Radiol (2008) 2.08
Laparoscopic living-donor nephrectomy: analysis of the existing literature. Eur Urol (2010) 2.07
High-risk prostate cancer: from definition to contemporary management. Eur Urol (2012) 2.06
Urodynamic parameters after retrourethral transobturator male sling and their influence on outcome. Urology (2011) 2.04
Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol (2005) 2.03
Contemporary management of postprostatectomy incontinence. Eur Urol (2011) 2.01
Is there a role for tamsulosin in the treatment of distal ureteral stones of 7 mm or less? Results of a randomised, double-blind, placebo-controlled trial. Eur Urol (2009) 1.87
Plasma vaporisation of the prostate: initial clinical results. Eur Urol (2009) 1.80
A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate. Eur Urol (2009) 1.78
A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur Urol (2009) 1.76
Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis. Eur Urol (2007) 1.74
Complications of the AdVance transobturator male sling in the treatment of male stress urinary incontinence. Urology (2010) 1.70
Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature. Eur Urol (2013) 1.69
Techniques and long-term results of surgical procedures for BPH. Eur Urol (2006) 1.65
Dual-energy CT in patients suspected of having renal masses: can virtual nonenhanced images replace true nonenhanced images? Radiology (2009) 1.63
Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy. Eur Urol (2011) 1.62
Laser fibre deterioration and loss of power output during photo-selective 80-w potassium-titanyl-phosphate laser vaporisation of the prostate. Eur Urol (2008) 1.62
Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future. Eur Urol (2006) 1.61
Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. J Urol (2010) 1.61
Perioperative morbidity of laparoscopic cryoablation of small renal masses with ultrathin probes: a European multicentre experience. Eur Urol (2009) 1.60
Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. Eur Urol (2008) 1.60
Preliminary results on the off-label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomy. Eur Urol (2006) 1.59
Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proc Natl Acad Sci U S A (2011) 1.59
Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome. Eur Urol (2010) 1.57
Life-threatening complication after right renal extracorporeal shock wave lithotripsy: large hepatic haematoma requiring embolisation of the right hepatic artery. Eur Urol (2007) 1.57
Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration-resistant disease. Endocr Relat Cancer (2013) 1.57
18F-Fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent. Eur Urol (2012) 1.54
Intermediate-term results of retroperitoneoscopy-assisted cryotherapy for small renal tumours using multiple ultrathin cryoprobes. Eur Urol (2006) 1.53
Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer. BJU Int (2013) 1.53
Sexual function after transurethral resection of the prostate (TURP): results of an independent prospective multicentre assessment of outcome. Eur Urol (2007) 1.52
Urological surgery and antiplatelet drugs after cardiac and cerebrovascular accidents. J Urol (2010) 1.52
High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol (2005) 1.51
Risk factors for pelvic lymphoceles post-radical prostatectomy. Int J Urol (2011) 1.51
Laparoscopy in German urology: changing acceptance among urologists. Eur Urol (2008) 1.51
Results of the AdVance transobturator male sling after radical prostatectomy and adjuvant radiotherapy. Urology (2010) 1.49
Urine markers for detection and surveillance of non-muscle-invasive bladder cancer. Eur Urol (2011) 1.49
The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol (2009) 1.49
The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis. Eur Urol (2013) 1.47
Immunohistochemical distribution of cyclic GMP-dependent protein kinase-1 in human prostate tissue. Eur Urol (2007) 1.46
Dual-energy computed tomography for the differentiation of uric acid stones: ex vivo performance evaluation. Urol Res (2008) 1.45
Comparison of a multi-layer structural model for arterial walls with a fung-type model, and issues of material stability. J Biomech Eng (2004) 1.45
Seven hours to adequate antimicrobial therapy in urosepsis using isothermal microcalorimetry. J Clin Microbiol (2013) 1.45
Postprostatectomy incontinence: all about diagnosis and management. Eur Urol (2008) 1.44
Lateral temperature spread of monopolar, bipolar and ultrasonic instruments for robot-assisted laparoscopic surgery. BJU Int (2014) 1.44
Tumour nephrectomy with vena cava thrombus. BJU Int (2005) 1.43
The complex structure of the smooth muscle layer of spermatic veins and its potential role in the development of varicocele testis. Eur Urol (2006) 1.43
The effect of increased maximum power output on perioperative and early postoperative outcome in photoselective vaporization of the prostate. Lasers Surg Med (2012) 1.41
Localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity. Eur Urol (2009) 1.40
Retroperitoneoscopic living donor nephrectomy: a retrospective comparison to the open approach. Transplantation (2004) 1.39
Potential consequences of low biopsy core number in selection of patients with prostate cancer for current active surveillance protocols. Urology (2013) 1.39
Comparison of CT angiography with MR angiography in the preoperative assessment of living kidney donors. Transplantation (2008) 1.39
KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clin Cancer Res (2011) 1.38
Is kidney surgery going to be minimally invasive in all cases? Eur Urol (2007) 1.38
Long-term experience with surgical and conservative treatment of penile fracture. J Urol (2004) 1.37
Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study. BJU Int (2008) 1.37
Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med (2010) 1.35
Loss of PBRM1 expression is associated with renal cell carcinoma progression. Int J Cancer (2012) 1.27
Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer. Prostate (2003) 1.26
Critical review of lasers in benign prostatic hyperplasia (BPH). BJU Int (2011) 1.25